IgE antibodies play a central role in allergic disease. They recognize allergens via their Fab regions, whilst their effector functions are controlled through interactions of the Fc region with two principal cell surface receptors, FcRI and CD23. Crosslinking of FcRI-bound IgE on mast cells and basophils by allergen initiates an immediate inflammatory response, while the interaction of IgE with CD23 on B-cells regulates IgE production. We have determined the structures of the C-type lectin "head" domain of CD23 from seven crystal forms. The thirty-five independent structures reveal extensive conformational plasticity in two loops that are critical for IgE binding.
Introduction
Immunoglobulin E (IgE) antibodies play a central role in allergic disease. They recognize allergens through their Fab regions, and interact with two principal cell surface receptors, FcRI and CD23, via their Fc regions (Gould and Sutton, 2008) . FcRI, found mainly on mast cells and basophils, binds IgE with high affinity Abbreviations: IgE, immunoglobulin E; ADAM10, a disintegrin and metalloproteinase domain-containing protein 10; NOE, nuclear Overhauser effect; PDB, Protein Data Bank.
* (K A = 10 10 -10 11 M −1 ) and is primarily responsible for allergic sensitization and the inflammatory response in which minute amounts of allergen crosslink FcRI-bound IgE, triggering cell degranulation. In contrast, IgE binding to CD23 (also known as FcRII) is central to the mechanism regulating IgE synthesis (Gould and Sutton, 2008) . CD23, expressed on B-cells, is unique amongst Ig receptors as it belongs to the C-type lectin-like domain superfamily (Zelensky and Gready, 2005) . It consists of three C-type lectin 'head' domains connected to the cell membrane via a trimeric ␣-helical coiled-coiled 'stalk'. A single head domain binds to IgE-Fc with an affinity of K A ∼ 10 6 M −1 , although the avidity of the trimer substantially enhances the interaction (McCloskey et al., 2007) . The stalk region of CD23 is susceptible to attack by various proteases to yield soluble trimeric (for instance, after site-specific cleavage with ADAM10 (Weskamp et al., 2006) ) as well as monomeric forms of CD23. Along with the membrane-bound form, soluble CD23 has been implicated in both positive and negative regulation of IgE synthesis (Gould and Sutton, 2008) . When expressed on gastrointestinal cells, CD23 is also involved in the transport of IgE-allergen complexes across the gut epithelial barrier, thus contributing to food allergenic reactions (Tu et al., 2005) . Similarly, CD23 expressed on respiratory tract epithelial cells promotes airway allergic inflammation (Palaniyandi et al., 2011 ). An understanding of the CD23-IgE interaction therefore has many implications for the prevention of allergic disease.
Materials and methods

Protein purification
Recombinant human derCD23 (Ser156-Glu298) was expressed, refolded and purified as previously described (Dhaliwal et al., 2012; Hibbert et al., 2005) .
Crystallization and data collection
During trials to crystallize various complexes of derCD23, six novel crystal forms of derCD23 alone were identified. Subsequent crystal optimizations used only derCD23.
All crystals were obtained by the hanging drop vapor diffusion method at 291 K and grew to their maximal size between four days and two weeks.
Prior to crystallization, derCD23 was concentrated and bufferexchanged into 25 mM Tris-HCl pH 7.5, 125 mM NaCl and 0.05% sodium azide. Crystals were obtained by mixing derCD23 with an equal volume of reservoir solution. Crystal forms A, B and C were grown by mixing 3.5 mg/ml derCD23 with 16% (w/v) PEG 6000, 2% (v/v) 1,6-hexanediol, 0.05 M ammonium sulfate and 0.1 M sodium acetate pH 4.7 (Yuan et al., 2013) ; 18% (w/v) PEG 6000, 2% (v/v) 1,6-hexanediol, 0.05 M ammonium sulfate and 0.1 M sodium acetate pH 4.5; and 25% (w/v) PEG 4000, 0.15 M ammonium sulfate and 0.1 M MES pH 5.5, respectively. Crystal form D was grown by mixing 5 mg/ml derCD23 with 22.5% (w/v) PEG 3350, 0.2 M ammonium sulfate and 0.1 M MES pH 5.5. Crystal form E grew by mixing 3.8 mg/ml derCD23 and 4 mM CaCl 2 with 30% (w/v) PEG 1500 and 0.1 M Malic acid: MES: Tris (MMT) buffer pH 4.25. Crystal form F was obtaining by mixing 4.4 mg/ml derCD23 with 22.5% (w/v) PEG 4000 and 0.1 M sodium citrate pH 4.75. Crystal form G were grown by mixing 2.2 mg/ml derCD23 with 3.7 M NaCl and 0.1 M citric acid pH 4.5.
The derCD23 crystals were cryoprotected and then flash-cooled in liquid nitrogen: crystals belonging to forms A, B, C, D and F were cryoprotected by soaking in reservoir solution containing an additional 20% (v/v) glycerol. No additional solution was required to cryoprotect crystals in form E. Crystals belonging to form G were cryoprotected by soaking in 100% (v/v) tacsimate (Hampton Research) pH 5.0. Diffraction data were collected at 100 K at Diamond Light Source synchrotron beamlines I02, I03, I04 and I24.
Structure determination
Indexing, integration, and merging of data were carried out with the HKL2000 (Otwinowski and Minor, 1997), MOSFLM (Battye et al., 2011; Powell, 1999) or XIA2 (Kabsch, 2010; Winter, 2010) suite of programs. The derCD23 structures were solved by molecular replacement with PHASER (McCoy et al., 2007) using the Ca 2+ -free derCD23 (PDB 4G96) (Yuan et al., 2013) crystal structures as the search model.
Crystal form A is the same as that of the previously determined wild-type derCD23 crystal structure (Yuan et al., 2013) . However, the four disulfide bridges (C160-C288, C163-C174, C191-C282 and C259-C273) that contribute to the tertiary structure are all intact; in the previous Ca 2+ -free crystal structure some of the cystine groups underwent radiation damage during X-ray data collection, leading to breakage of some of the disulfide bonds.
Due to the high degree of non-crystallographic symmetry (NCS) in crystal forms B, C and D, reflections were selected for the R free set in thin resolution shells (Fabiola et al., 2006) in the corresponding datasets. Iterative cycles of refinement using PHENIX (Adams et al., 2011) , REFMAC5 and BUSTER-TNT (Smart et al., 2012 ) alternated with manual model building with COOT (Emsley et al., 2010) . The model was built into 2F o − F c composite omit, 2F o − F c and F o − F c electron density maps in order to minimize model bias. Initially during refinement, tight NCS restraints were used. These were gradually relaxed, and local structure similarity restraints (or "local NCS") Smart et al., 2012) applied. During the final cycles of refinement, NCS restraints were released for the structures from crystal forms A, E, F and G. TLS groups (Painter and Merritt, 2005) were generated using the TLSMD Web server (Painter and Merritt, 2006) . Data processing and refinement statistics are shown in Table 1 . Fig. 1 shows the seven asymmetric units identified.
The software, Hingefind (Wriggers and Schulten, 1997) , DynDom (Hayward and Berendsen, 1998) , Contact and PISA (Krissinel and Henrick, 2007) were used for structural analysis. All figures presented were generated using PyMOL (Schrödinger, 2011) .
Results and discussion
Previously, we determined the crystal structure of a complex between the soluble monomeric lectin head domain of CD23 (termed derCD23, as it corresponds to a fragment generated by the house dust mite allergenic protease Der p 1 (Schulz et al., 1997) ) and a sub-fragment of IgE-Fc consisting of the dimer of C3 and C4 domains, termed Fc3-4 (Dhaliwal et al., 2012) . The complex shows one CD23 head domain binding to each heavy chain of IgE, explaining the known 2:1 stoichiometry (Dhaliwal et al., 2012; McCloskey et al., 2007; Shi et al., 1997) . Furthermore we showed that the binding of FcRI and CD23 to IgE-Fc are allosterically linked: although the binding sites for the two receptors are distant from each other, conformational changes in Fc3-4 upon derCD23 binding preclude binding of FcRI, and vice versa (Dhaliwal et al., 2012) . Conformational changes in free Fc3-4 (Wurzburg and Jardetzky, 2009), and upon FcRI binding to Fc3-4 (Garman et al., 2000) or IgE-Fc (Holdom et al., 2011) , have also been described.
The binding of derCD23 to Fc3-4 is predominantly hydrophilic, involving four salt bridges with hydrogen bonding, and four additional hydrogen bonds. Arg440 in the C3-C4 linker region of Fc3-4 forms two hydrogen bonds with Ser254 in loop 4 of derCD23 (Dhaliwal et al., 2012) , but this loop is partially disordered (at residues 256 and 257) in the complex. We have recently shown that calcium binding to CD23 enhances its affinity for IgE by binding to the base of loop 4, inducing a trans to cis isomerization of Pro250 and concomitant ordering and change in conformation of the loop (Yuan et al., 2013) . The re-positioned side-chain of Asp258 forms a salt bridge and two new hydrogen bonds with Arg440 of IgE, and the calcium-dependent movement of loop 4 is coupled with conformational changes in loop 1 (Leu226-Glu231) enabling Asp227 to form a salt bridge and two further hydrogen bonds with Arg440 (Yuan et al., 2013) . Both loops thus contribute additionally to IgE binding in the presence of calcium.
In this study, we have determined and compared the structures of derCD23 head domains from six new crystal forms together with a previously identified crystal form (Yuan et al., 2013) . These structures provide thirty-five independent views of unbound, Ca 2+ -free derCD23, allowing a comprehensive examination of the conformational variation in the IgE-binding site of CD23. The derCD23 structures show little difference in secondary structure or packing of the core, with C␣ r.m.s. deviations ranging from 0.1 to 1.6Å (over 120 C␣ pairs). However, there is considerable plasticity within the IgE-binding loops 1 and 4 ( Fig. 2(a) ). In addition to conformations that are intermediate between those observed in earlier Ca 2+ -free (Weiss, 2001 ). e Rxpct = hkl ||F obs | − |Fxpct||/ hkl |F obs |, where |F obs | and |Fxpct| are the observed structure factor amplitude and the expectation of the model structure factor amplitude, respectively (Blanc et al., 2004) . f R free equals the Rxpct of test set (5% of the data removed prior to refinement). g Water molecules and SO4 2− ions. h R.m.s. deviation between B factors for bonded main-chain atoms.
i As defined by MolProbity (Chen et al., 2010) . and Ca 2+ -bound derCD23 (Yuan et al., 2013) , loops 1 and 4 are also found to adopt more 'extreme' conformations, lying closer together (e.g. molecule D in crystal form F) or further apart (e.g. molecule A in crystal form G) than had been seen in any of the earlier structures. In an NMR analysis of derCD23 in solution, residues 253-257 of loop 4 could not be assigned, indicative of mobility on the ms to s timescale (Hibbert et al., 2005) .
Remarkably, all thirty-five of the derCD23 structures can be modeled onto the derCD23-Fc3-4 crystal structure without any clashes with the antibody, suggesting that all conformations that the head domain of CD23 may adopt free in solution are capable of interacting directly with IgE. Not all thirty-five conformations would make the same number of initial contacts with IgE of course, but upon binding, loops 1 and 4 adopt a single conformation, with (Wriggers and Schulten, 1997 ) (Arg224/Asn225 and Phe232 for loop 1, and Pro250 and Asp258 for loop 4) and Asp227 (an IgE interacting residue) are depicted. Also shown is a hydrogen bond between the two loops that is common to all derCD23 structures. (c) Loop 4 from three derCD23 structures superimposed on the atoms of Pro250. The loops depicted are the same as those in (b), along with an "intermediary" loop, molecule E from crystal form B (blue). The Pro250 residues from the Ca 2+ -bound and intermediary (Ca 2+ -free) structures (numbered 3 and 2 respectively) are in a cis-configuration, while the other Pro250 adopts a trans-configuration (numbered 1). the exception of residues 256 and 257 of loop 4 which remain disordered (Dhaliwal et al., 2012) . Only in the presence of Ca 2+ is loop 4 stabilized in its entirety (Yuan et al., 2013) .
Further analysis of the array of derCD23 structures revealed the mechanism by which the movements of loops 1 and 4 are coupled ( Fig. 2(b) ): they are linked via at least one hydrogen bond, namely Asn225-Asp258 in all structures, and a number of van der Waals interactions that ranges from nine (in molecule E of crystal form B, with a partially disordered loop 1) to fifty-two (in molecule D of crystal form F). Moreover, twenty of the thirty-five structures have cis configurations for Pro250, while the remainder are trans (Fig. 2(c) ), implying that in solution the peptide bond is equally likely to be cis or trans in the absence of calcium; it becomes "locked" as cis only upon Ca 2+ binding (Yuan et al., 2013) .
Taken together with the knowledge that the Fc3-4 region of IgE-Fc exhibits inter-domain flexibility (Wurzburg and Jardetzky, 2009) , the extreme loop flexibility in the IgE-binding site of CD23 revealed here presents a picture of two dynamic binding partners. This interaction has potential as a drug target for modulation of IgE production (Rosenwasser and Meng, 2005) , and although dynamic targets present difficulties for conventional structurebased inhibitor design, they do offer possibilities for allosteric intervention. Stabilization of less favorable binding conformations is thus a promising strategy, guided by the range of CD23 structures presented here.
